Modulation of gene expression in U251 glioblastoma cells by binding of mutant p53 R273H to intronic and intergenic sequences
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Missense point mutations in the TP53 gene are frequent genetic alterations in human tumor tissue and cell lines derived thereof. Mutant p53 (mutp53) proteins have lost sequence-specific DNA binding, but have retained the ability to interact in a structure-selective manner with non-B DNA and to act as regulators of transcription. To identify functional binding sites of mutp53, we established a small library of genomic sequences bound by p53(R273H) in U251 human glioblastoma cells using chromatin immunoprecipitation (ChIP). Mutp53 binding to isolated DNA fragments confirmed the specificity of the ChIP. The mutp53 bound DNA sequences are rich in repetitive DNA elements, which are dispersed over non-coding DNA regions. Stable down-regulation of mutp53 expression strongly suggested that mutp53 binding to genomic DNA is functional. We identified the PPARGC1A and FRMD5 genes as p53(R273H) targets regulated by binding to intronic and intra-genic sequences. We propose a model that attributes the oncogenic functions of mutp53 to its ability to interact with intronic and intergenic non-B DNA sequences and modulate gene transcription via re-organization of chromatin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Petitjean, A., Mathe, E., Kato, S., Ishioka, C., Tavtigian, S. V., Hainaut, P., & Olivier, M. (2007) · Human Mutation · doi:10.1002/humu.20495 · Cited by 1,598 · cited 2×
“These domains are rarely mutated in human tumor cells (2,3) and are crucial for interactions with proteins of transcription complexes (15,16).”
BackgroundDefects in Adaptive Energy Metabolism with CNS-Linked Hyperactivity in PGC-1α Null Mice
Lin, J., Wu, P.-H., Tarr, P. T., Lindenberg, K. S., St-Pierre, J., Zhang, C.-Y., Mootha, V. K., Jäger, S., Vianna, C. R., Reznick, R. M., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.013 · Cited by 1,162
A Global Map of p53 Transcription-Factor Binding Sites in the Human Genome
Wei, C.-L., Wu, Q., Vega, V. B., Chiu, K. P., Ng, P., Zhang, T., Shahab, A., Yong, H. C., Fu, Y., Weng, Z., et al. (2006) · Cell · doi:10.1016/j.cell.2005.10.043 · Cited by 1,141 · cited 2×
“The specificity of the monoclonal antibodies DO1 and Pab421 has been already documented (54,55).”
BackgroundTP53 mutations in human cancers: Functional selection and impact on cancer prognosis and outcomes
Petitjean, A., Achatz, M. I. W., Borresen-Dale, A. L., Hainaut, P., & Olivier, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210302 · Cited by 884 · cited 2×
“These domains are rarely mutated in human tumor cells (2,3) and are crucial for interactions with proteins of transcription complexes (15,16).”
BackgroundLi, Q., Peterson, K. R., Fang, X., & Stamatoyannopoulos, G. (2002) · Blood · doi:10.1182/blood-2002-04-1104 · Cited by 456
Di Agostino, S., Strano, S., Emiliozzi, V., Zerbini, V., Mottolese, M., Sacchi, A., Blandino, G., & Piaggio, G. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.013 · Cited by 418 · cited 2×
“Transcriptional regulation of such genes by mutp53 has been demonstrated previously, and can be achieved by an altered sequence-specificity of mutp53 proteins (12), and by its interaction with other transcription factors, like SP1, Ets1 and NF-Y (9–11).”
BackgroundRemote control of gene transcription
West, A. G., & Fraser, P. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi104 · Cited by 302
A functional p53-responsive intronic promoter is contained within the human mdm2 gene
Zauberman, A., Flusberg, D., Haupt, Y., Barak, Y., & Oren, M. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.14.2584 · Cited by 276
Chen, J., & Sadowski, I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407069102 · Cited by 111
Menendez, D., Inga, A., & Resnick, M. A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2297-2308.2006 · Cited by 81
Research works printed but not linked: 70
- Soussi, 2005, Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations, Hum. Mutat, 25, 6, 10.1002/humu.20114 · DOI · Paper page
- Ma, 2007, Probing potential binding modes of the p53 tetramer to DNA based on the symmetries encoded in p53 response elements, Nucleic Acids Res, 35, 7733, 10.1093/nar/gkm890 · DOI
- Ang, 2006, Effects of common cancer mutations on stability and DNA binding of full-length p53 compared with isolated core domains, J. Biol. Chem, 281, 21934, 10.1074/jbc.M604209200 · DOI · Paper page
- Gohler, 2005, Mutant p53 proteins bind DNA in a DNA structure-selective mode, Nucleic Acids Res, 33, 1087, 10.1093/nar/gki252 · DOI · Paper page
- Kim, 2004, Transcriptional activities of mutant p53: when mutations are more than a loss, J. Cell Biochem, 93, 878, 10.1002/jcb.20271 · DOI · Paper page
- Weisz, 2007, Transcription regulation by mutant p53, Oncogene, 26, 2202, 10.1038/sj.onc.1210294 · DOI · Paper page
- Chicas, 2000, Mutant p53 forms a complex with Sp1 on HIV-LTR DNA, Biochem. Biophys. Res. Commun, 279, 383, 10.1006/bbrc.2000.3965 · DOI
- Xu, 2002, Ets1 is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells, EMBO J, 21, 4081, 10.1093/emboj/cdf413 · DOI
- Matas, 2001, Integrity of the N-terminal transcription domain of p53 is required for mutant p53 interference with drug-induced apoptosis, EMBO J, 20, 4163, 10.1093/emboj/20.15.4163 · DOI
- Frazier, 1998, Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain, Mol. Cell Biol, 18, 3735, 10.1128/MCB.18.7.3735 · DOI · Paper page
- Espinosa, 2001, Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment, Mol. Cell, 8, 57, 10.1016/S1097-2765(01)00283-0 · DOI · Paper page
- Liu, 2001, Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor protein, J. Mol. Biol, 313, 711, 10.1006/jmbi.2001.5082 · DOI
- Istrail, 2005, Logic functions of the genomic cis-regulatory code, Proc. Natl Acad. Sci. USA, 102, 4954, 10.1073/pnas.0409624102 · DOI · Paper page
- de Laat, 2003, Spatial organization of gene expression: the active chromatin hub, Chromosome Res, 11, 447, 10.1023/A:1024922626726 · DOI · Paper page
- Gaszner, 2006, Insulators: exploiting transcriptional and epigenetic mechanisms, Nat. Rev. Genet, 7, 703, 10.1038/nrg1925 · DOI · Paper page
- Gluch, 2008, Scaffold/matrix attachment regions (S/MARs): relevance for disease and therapy, Handb. Exp. Pharmacol, 186, 67, 10.1007/978-3-540-72843-6_4 · DOI
- Razin, 1995, Specificity and functional significance of DNA interaction with the nuclear matrix: new approaches to clarify the old questions, Int. Rev. Cytol, 162B, 405
- Berezney, 1995, The nuclear matrix: a structural milieu for genomic function, Int. Rev. Cytol, 162A, 1
- Bode, 2006, Correlations between scaffold/matrix attachment region (S/MAR) binding activity and DNA duplex destabilization energy, J. Mol. Biol, 358, 597, 10.1016/j.jmb.2005.11.073 · DOI
- Koga, 2000, Identification of genomic DNA sequences bound by mutant p53 protein (Gly245–>Ser) in vivo, Oncogene, 19, 4178, 10.1038/sj.onc.1203745 · DOI
- Deppert, 1996, Binding of MAR-DNA elements by mutant p53: possible implications for its oncogenic functions, J. Cell Biochem, 62, 172, 10.1002/(SICI)1097-4644(199608)62:2<172::AID-JCB5>3.0.CO;2-P · doi:10.1002/(sici)1097-4644(199608)62:2<172::aid-jcb5>3.0.co;2-p
- Weissker, 1992, Specific and complex interactions of murine p53 with DNA, Oncogene, 7, 1921
- Will, 1998, High affinity MAR-DNA binding is a common property of murine and human mutant p53, J. Cell Biochem, 69, 260, 10.1002/(SICI)1097-4644(19980601)69:3<260::AID-JCB4>3.0.CO;2-P · DOI
- Will, 1998, Specific interaction of mutant p53 with regions of matrix attachment region DNA elements (MARs) with a high potential for base-unpairing, Proc. Natl Acad. Sci. USA, 95, 13681, 10.1073/pnas.95.23.13681 · DOI · Paper page
- Orlando, 1997, Analysis of chromatin structure by in vivo formaldehyde cross-linking, Methods, 11, 205, 10.1006/meth.1996.0407 · DOI · Paper page
- Tolstonog, 2001, Isolation of SDS-stable complexes of the intermediate filament protein vimentin with repetitive, mobile, nuclear matrix attachment region, and mitochondrial DNA sequence elements from cultured mouse and human fibroblasts, DNA Cell Biol, 20, 531, 10.1089/104454901317094954 · DOI
- Brummelkamp, 2002, A system for stable expression of short interfering RNAs in mammalian cells, Science, 296, 550, 10.1126/science.1068999 · DOI · Paper page
- Chen, 2005, Real-time quantification of microRNAs by stem-loop RT-PCR, Nucleic Acids Res, 33, e179, 10.1093/nar/gni178 · DOI · Paper page
- Kent, 2002, BLAT–the BLAST-like alignment tool, Genome Res, 12, 656, 10.1101/gr.229202 · DOI · Paper page
- Halees, 2004, PromoSer: improvements to the algorithm, visualization and accessibility, Nucleic Acids Res, 32, W191, 10.1093/nar/gkh433 · DOI
- Hackl, 2005, Molecular processes during fat cell development revealed by gene expression profiling and functional annotation, Genome Biol, 6, R108, 10.1186/gb-2005-6-13-r108 · DOI · Paper page
- Singh, 1997, Mathematical model to predict regions of chromatin attachment to the nuclear matrix, Nucleic Acids Res, 25, 1419, 10.1093/nar/25.7.1419 · DOI · Paper page
- Thomas-Chollier, 2008, RSAT: regulatory sequence analysis tools, Nucleic Acids Res, 36, W119, 10.1093/nar/gkn304 · DOI · Paper page
- Grillo, 2003, PatSearch: A program for the detection of patterns and structural motifs in nucleotide sequences, Nucleic Acids Res, 31, 3608, 10.1093/nar/gkg548 · DOI · Paper page
- Brazdova, 2002, Role of tumor suppressor p53 domains in selective binding to supercoiled DNA, Nucleic Acids Res, 30, 4966, 10.1093/nar/gkf616 · DOI
- Schmittgen, 2008, Analyzing real-time PCR data by the comparative C(T) method, Nat. Protoc, 3, 1101, 10.1038/nprot.2008.73 · DOI · Paper page
- Britanova, 2005, Novel transcription factor Satb2 interacts with matrix attachment region DNA elements in a tissue-specific manner and demonstrates cell-type-dependent expression in the developing mouse CNS, Eur. J. Neurosci, 21, 658, 10.1111/j.1460-9568.2005.03897.x · DOI · Paper page
- Nickerson, 1997, The nuclear matrix revealed by eluting chromatin from a cross-linked nucleus, Proc. Natl Acad. Sci. USA, 94, 4446, 10.1073/pnas.94.9.4446 · DOI · Paper page
- He, 2008, Chromatin organization and nuclear microenvironments in cancer cells, J. Cell Biochem, 104, 2004, 10.1002/jcb.21485 · DOI
- Carter, 2008, Transcription factories, Biochem. Soc. Trans, 36, 585, 10.1042/BST0360585 · DOI · Paper page
- Stein, 2004, Nuclear microenvironments support assembly and organization of the transcriptional regulatory machinery for cell proliferation and differentiation, J. Cell Biochem, 91, 287, 10.1002/jcb.10777 · DOI
- van Wijnen, 1993, Nuclear matrix association of multiple sequence-specific DNA binding activities related to SP-1, ATF, CCAAT, C/EBP, OCT-1, and AP-1, Biochemistry, 32, 8397, 10.1021/bi00084a003 · DOI · Paper page
- Guo, 1995, The nuclear matrix protein NMP-1 is the transcription factor YY1, Proc. Natl Acad. Sci. USA, 92, 10526, 10.1073/pnas.92.23.10526 · DOI · Paper page
- Koutsodontis, 2005, Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis, Biochem. J, 389, 443, 10.1042/BJ20041980 · DOI · Paper page
- Sui, 2004, Yin Yang 1 is a negative regulator of p53, Cell, 117, 859, 10.1016/j.cell.2004.06.004 · DOI · Paper page
- Guelen, 2008, Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions, Nature, 453, 948, 10.1038/nature06947 · DOI · Paper page
- Luderus, 1992, Binding of matrix attachment regions to lamin B1, Cell, 70, 949, 10.1016/0092-8674(92)90245-8 · DOI
- Hearnes, 2005, Chromatin immunoprecipitation-based screen to identify functional genomic binding sites for sequence-specific transactivators, Mol. Cell Biol, 25, 10148, 10.1128/MCB.25.22.10148-10158.2005 · DOI · Paper page
- Greig, 1992, Beta satellite DNA: characterization and localization of two subfamilies from the distal and proximal short arms of the human acrocentric chromosomes, Genomics, 12, 573, 10.1016/0888-7543(92)90450-7 · DOI
- Eichler, 1998, Complex beta-satellite repeat structures and the expansion of the zinc finger gene cluster in 19p12, Genome Res, 8, 791, 10.1101/gr.8.8.791 · DOI · Paper page
- Sbisa, 2007, p53FamTaG: a database resource of human p53, p63 and p73 direct target genes combining in silico prediction and microarray data, BMC Bioinformatics, 8, S20, 10.1186/1471-2105-8-S1-S20 · DOI · Paper page
- Frank-Kamenetskii, 1995, Triplex DNA structures, Annu. Rev. Biochem, 64, 65, 10.1146/annurev.bi.64.070195.000433 · DOI · Paper page
- Mazur, 1999, Preferential binding of tumor suppressor p53 to positively or negatively supercoiled DNA involves the C-terminal domain, J. Mol. Biol, 292, 241, 10.1006/jmbi.1999.3064 · DOI
- Palecek, 2004, Enhancement of p53 sequence-specific binding by DNA supercoiling, Oncogene, 23, 2119, 10.1038/sj.onc.1207324 · DOI
- Reczek, 2003, Multiple response elements and differential p53 binding control Perp expression during apoptosis, Mol. Cancer Res, 1, 1048
- Joerger, 2005, Structures of p53 cancer mutants and mechanism of rescue by second-site suppressor mutations, J. Biol. Chem, 280, 16030, 10.1074/jbc.M500179200 · DOI · Paper page
- Hinow, 2006, The DNA binding activity of p53 displays reaction-diffusion kinetics, Biophys. J, 91, 330, 10.1529/biophysj.105.078303 · DOI
- Mueller, 2008, Evidence for a common mode of transcription factor interaction with chromatin as revealed by improved quantitative fluorescence recovery after photobleaching, Biophys. J, 94, 3323, 10.1529/biophysj.107.123182 · DOI · Paper page
- Xiao, 1994, Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53, Mol. Cell Biol, 14, 7013, 10.1128/MCB.14.10.7013 · DOI · Paper page
- Jurka, 2007, Repetitive sequences in complex genomes: structure and evolution, Annu. Rev. Genomics Hum. Genet, 8, 241, 10.1146/annurev.genom.8.080706.092416 · DOI · Paper page
- Zuckerkandl, 2007, Combinatorial epigenetics, ‘junk DNA’, and the evolution of complex organisms, Gene, 390, 232, 10.1016/j.gene.2006.12.001 · DOI
- Hanke, 1995, Repetitive Alu elements form a cruciform structure that regulates the function of the human CD8 alpha T cell-specific enhancer, J. Mol. Biol, 246, 63, 10.1006/jmbi.1994.0066 · DOI
- Howell, 1997, The ability to form intrastrand tetraplexes is an evolutionarily conserved feature of the 3′ end of L1 retrotransposons, Mol. Biol. Evol, 14, 144, 10.1093/oxfordjournals.molbev.a025747 · DOI
- Li, 2008, Transcription factors bind thousands of active and inactive regions in the Drosophila blastoderm, PLoS Biol, 6, e27, 10.1371/journal.pbio.0060027 · DOI · Paper page
- Jackson, 2003, The principles of nuclear structure, Chromosome Res, 11, 387, 10.1023/A:1024954123092 · DOI
- Cremer, 2001, Chromosome territories, nuclear architecture and gene regulation in mammalian cells, Nat. Rev. Genet, 2, 292, 10.1038/35066075 · DOI · Paper page
- Jiang, 2003, Expression of peroxisome-proliferator activated receptor-gamma (PPARgamma) and the PPARgamma co-activator, PGC-1, in human breast cancer correlates with clinical outcomes, Int. J. Cancer, 106, 752, 10.1002/ijc.11302 · DOI · Paper page
- Olivier, 2006, The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer, Clin. Cancer Res, 12, 1157, 10.1158/1078-0432.CCR-05-1029 · DOI · Paper page
- Bossi, 2008, Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor malignancy, Cell Cycle, 7, 1870, 10.4161/cc.7.12.6161 · DOI · Paper page
- Heinlein, 2008, Mutant p53(R270H) gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis, Int. J. Cancer, 122, 1701, 10.1002/ijc.23317 · DOI · Paper page
Cited by
Mutant p53: one name, many proteins
Freed-Pastor, W. A., & Prives, C. (2012) · Genes & Development · doi:10.1101/gad.190678.112 · Cited by 1,247
When mutants gain new powers: News from the mutant p53 field
Brosh, R., & Rotter, V. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2693 · Cited by 1,132
“Supporting these data, DNA sequences bound by mutant p53 are rich in repetitive elements and other sequences with a high likelihood of adopting non-B conformation”
BackgroundThe p53 Pathway in Glioblastoma
Zhang, Y., Dube, C., Gibert, M., Cruickshanks, N., Wang, B., Coughlan, M., Yang, Y., Setiady, I., Deveau, C., Saoud, K., et al. (2018) · Cancers · doi:10.3390/cancers10090297 · Cited by 440
Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme
England, B., Huang, T., & Karsy, M. (2013) · Tumor Biology · doi:10.1007/s13277-013-0871-3 · Cited by 163
“In GBM, analysis of genomic expression in a mutant p53 cell line (U251) indicated upregulation ofmultiple genes previously associated with tumorigenesis, including: JAK2 (janus kinase 2), C3ORF26, FRMD5 (FERM domain containing 5), CYFIP2 (cytoplasmic FMR1 interacting protein 2), neuregulin 1 (NRG1), PPARGC1A (peroxiso…”
BackgroundOmoruyi, S. I., Ekpo, O. E., Semenya, D. M., Jardine, A., & Prince, S. (2020) · Apoptosis · doi:10.1007/s10495-020-01594-5 · Cited by 53
Liquid biopsy: creating opportunities in brain space
Trivedi, R., & Bhat, K. P. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02446-0 · Cited by 27
Metadata
- Authors
- Brázdová, M., Quante, T., Tögel, L., Walter, K., Loscher, C., Tichý, V., Činčárová, L., Deppert, W., & Tolstonog, G. V.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-01-12
- Volume
- 37
- Issue
- 5
- Pages
- 1486-1500
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2010363079
- Cited by
- 72
- References
- 10
- FWCI
- 1.34
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.